The article is all about why "0.05" might be a bad value to choose. But, more fundamentally, p is often the wrong thing to be looking at in the first place. 1. Effect sizes. Suppose you are a doctor or a patient and you are interested in two drugs. Both are known to be safe (maybe they've been used for decades for some problem other than the one you're now facing). As for efficacy against the problem you have, one ha…
I think if hypothesis testing is understood properly, these objections don't have much teeth. 1. Typically we use p-values to construct confidence intervals, answering the concern about quantifying the effect size. (That is, the confidence interval is the collection of all values not rejected by the hypothesis test.) 2. P-values control type I error. Well-powered designs control type I and type II error. Good control…
But looking at the practical application, in particular the replication crisis, specification curve analysis, de facto power of published studies and many more, we see that there is an immense practical problem and p-values are not making it better.
We need to criticize p-values and NHST hard, not because they cannot be used correctly, but because they are not used correctly (and are arguably hard to use right, see the Gigerenzer paper I linked).